These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 17319154

  • 21. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
    Matsui K, Gromowski GD, Li L, Schuh AJ, Lee JC, Barrett AD.
    Virology; 2009 Feb 05; 384(1):16-20. PubMed ID: 19101005
    [Abstract] [Full Text] [Related]

  • 22. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange.
    Abou-Jaoudé G, Sureau C.
    J Virol; 2007 Dec 05; 81(23):13057-66. PubMed ID: 17898062
    [Abstract] [Full Text] [Related]

  • 23. Antigenic characterization of bovine ephemeral fever rhabdovirus G and GNS glycoproteins expressed from recombinant baculoviruses.
    Johal J, Gresty K, Kongsuwan K, Walker PJ.
    Arch Virol; 2008 Dec 05; 153(9):1657-65. PubMed ID: 18626567
    [Abstract] [Full Text] [Related]

  • 24. The pH dependence of flavivirus envelope protein structure: insights from molecular dynamics simulations.
    Fuzo CA, Degrève L.
    J Biomol Struct Dyn; 2014 Dec 05; 32(10):1563-74. PubMed ID: 23964620
    [Abstract] [Full Text] [Related]

  • 25. Enzyme-linked immunosorbent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of flavivirus infections.
    Chiou SS, Crill WD, Chen LK, Chang GJ.
    Clin Vaccine Immunol; 2008 May 05; 15(5):825-35. PubMed ID: 18337381
    [Abstract] [Full Text] [Related]

  • 26. Structures and Functions of the Envelope Glycoprotein in Flavivirus Infections.
    Zhang X, Jia R, Shen H, Wang M, Yin Z, Cheng A.
    Viruses; 2017 Nov 13; 9(11):. PubMed ID: 29137162
    [Abstract] [Full Text] [Related]

  • 27. The Zika virus envelope protein glycan loop regulates virion antigenicity.
    Goo L, DeMaso CR, Pelc RS, Ledgerwood JE, Graham BS, Kuhn RJ, Pierson TC.
    Virology; 2018 Feb 13; 515():191-202. PubMed ID: 29304471
    [Abstract] [Full Text] [Related]

  • 28. The role of anti-flavivirus humoral immune response in protection and pathogenesis.
    Hurtado-Monzón AM, Cordero-Rivera CD, Farfan-Morales CN, Osuna-Ramos JF, De Jesús-González LA, Reyes-Ruiz JM, Del Ángel RM.
    Rev Med Virol; 2020 Jul 13; 30(4):e2100. PubMed ID: 32101633
    [Abstract] [Full Text] [Related]

  • 29. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT, Boo I, Drummer HE, Netter HJ.
    Antivir Ther; 2007 Jul 13; 12(4):477-87. PubMed ID: 17668556
    [Abstract] [Full Text] [Related]

  • 30. Selection and analysis of mutations in an encephalomyocarditis virus internal ribosome entry site that improve the efficiency of a bicistronic flavivirus construct.
    Orlinger KK, Kofler RM, Heinz FX, Hoenninger VM, Mandl CW.
    J Virol; 2007 Nov 13; 81(22):12619-29. PubMed ID: 17855533
    [Abstract] [Full Text] [Related]

  • 31. Molecular basis of antibody-mediated neutralization and protection against flavivirus.
    Dai L, Wang Q, Qi J, Shi Y, Yan J, Gao GF.
    IUBMB Life; 2016 Oct 13; 68(10):783-91. PubMed ID: 27604155
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody.
    Cherrier MV, Kaufmann B, Nybakken GE, Lok SM, Warren JT, Chen BR, Nelson CA, Kostyuchenko VA, Holdaway HA, Chipman PR, Kuhn RJ, Diamond MS, Rossmann MG, Fremont DH.
    EMBO J; 2009 Oct 21; 28(20):3269-76. PubMed ID: 19713934
    [Abstract] [Full Text] [Related]

  • 34. Flavivirus serology by Western blot analysis.
    Oceguera LF, Patiris PJ, Chiles RE, Busch MP, Tobler LH, Hanson CV.
    Am J Trop Med Hyg; 2007 Jul 21; 77(1):159-63. PubMed ID: 17620648
    [Abstract] [Full Text] [Related]

  • 35. Quaternary protein mimetics of gp41 elicit neutralizing antibodies against HIV fusion-active intermediate state.
    Sadler K, Zhang Y, Xu J, Yu Q, Tam JP.
    Biopolymers; 2008 Jul 21; 90(3):320-9. PubMed ID: 18338371
    [Abstract] [Full Text] [Related]

  • 36. Conserved leucine residue in the head region of morbillivirus fusion protein regulates the large conformational change during fusion activity.
    Plattet P, Langedijk JP, Zipperle L, Vandevelde M, Orvell C, Zurbriggen A.
    Biochemistry; 2009 Sep 29; 48(38):9112-21. PubMed ID: 19705836
    [Abstract] [Full Text] [Related]

  • 37. The Many Faces of a Dynamic Virion: Implications of Viral Breathing on Flavivirus Biology and Immunogenicity.
    Dowd KA, Pierson TC.
    Annu Rev Virol; 2018 Sep 29; 5(1):185-207. PubMed ID: 30265634
    [Abstract] [Full Text] [Related]

  • 38. The importance of being outer: consequences of the distinction between the outer and inner surfaces of flavivirus glycoprotein E.
    Seligman SJ, Bucher DJ.
    Trends Microbiol; 2003 Mar 29; 11(3):108-10. PubMed ID: 12648938
    [Abstract] [Full Text] [Related]

  • 39. Degrees of maturity: the complex structure and biology of flaviviruses.
    Pierson TC, Diamond MS.
    Curr Opin Virol; 2012 Apr 29; 2(2):168-75. PubMed ID: 22445964
    [Abstract] [Full Text] [Related]

  • 40. Capturing a flavivirus pre-fusion intermediate.
    Kaufmann B, Chipman PR, Holdaway HA, Johnson S, Fremont DH, Kuhn RJ, Diamond MS, Rossmann MG.
    PLoS Pathog; 2009 Nov 29; 5(11):e1000672. PubMed ID: 19956725
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.